ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

DCBD Board Approved Concepts For New Grants In Cytogenetics Solid Tumor Diagnoses

December 13, 1984

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds

October 27, 2006

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007